Evaluating the Effect of Rosemary on Sleep Quality, Anxiety and Depression in Elderly

Evaluating the Effect of Rosemary (Salvia rosmarinus Spenn) on Sleep Quality, Anxiety and Depression in Elderly Nursing Home Residents: a Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110310006026N14

Enrollment

Registered

2025-08-18

Start date

2025-10-10

Completion date

Unknown

Last updated

2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Sleep quality. Condition 2: Anxiety. Condition 3: Depression. Sleep disorders Generalized anxiety disorder Major depressive disorder, single episode

Interventions

Intervention 1: Intervention group: Elderly individuals receive one capsule containing 750 mg of rosemary (the drug is safe at this dose) every evening for 4 weeks. Intervention 2: Control group: Elde

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: People = 65 years of age residing in nursing homes

Exclusion criteria

Exclusion criteria: People with rosemary allergies People taking sleeping pills, anti-anxiety medications, and sedatives

Design outcomes

Primary

Measure	Time frame
Score of sleep quality. Timepoint: At the beginning (before the intervention) and 4 weeks after the start of rosemary consumption. Method of measurement: Pittsburgh Sleep Quality Inventory (PSQI).;Anxiety score. Timepoint: At the beginning (before the intervention) and 4 weeks after the start of rosemary consumption. Method of measurement: Hospital Anxiety and Depression Scale (HADS).;Depression score. Timepoint: At the beginning (before the intervention) and 4 weeks after the start of rosemary consumption. Method of measurement: Hospital Anxiety and Depression Scale (HADS).	—

Measure

Time frame

Score of sleep quality. Timepoint: At the beginning (before the intervention) and 4 weeks after the start of rosemary consumption. Method of measurement: Pittsburgh Sleep Quality Inventory (PSQI).;Anxiety score. Timepoint: At the beginning (before the intervention) and 4 weeks after the start of rosemary consumption. Method of measurement: Hospital Anxiety and Depression Scale (HADS).;Depression score. Timepoint: At the beginning (before the intervention) and 4 weeks after the start of rosemary consumption. Method of measurement: Hospital Anxiety and Depression Scale (HADS).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Dabaghzadeh

Kerman University of Medical Sciences

fatemeh.dabaghzadeh@gmail.com+98 34 3132 5034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026